Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesCardiologywellsense_health_plan secondary hypercoagulable st…
    Ask Trek AI about this page
    Currentwellsense_health_planPolicy N/A

    Secondary Hypercoagulable State Documentation Best Practices

    Customize your policy alerts

    Sign up for all wellsense_health_plan policy alerts

    Know when wellsense_health_plan releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Guidance for clinicians on documenting secondary hypercoagulable states (eg, due to atrial fibrillation, COVID-19, or active cancer) to support accurate diagnosis capture and coding for Wellsense Health Plan members.

    Policy Summary
    Payerwellsense_health_plan
    PolicySecondary Hypercoagulable State Documentation Best Practices
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateN/A
    Next Review DateN/A
    Key ActionDocument the primary condition causing the hypercoagulable state and link it explicitly to the secondary hypercoagulable state (eg, 'due to' or 'secondary to') and include assessment and plan for both.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    D68.69ICD-10 code cited
    CHA2DS2-VAScRisk score referenced
    2Example cases

    Coverage Criteria

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Documentation sufficiency

    Covered when ALL of the following documentation elements are present

    Documentation linkage and causation: Primary condition accountable for the hypercoagulable state is identified and its status documented

    Examples: atrial fibrillation, COVID-19, malignancy

    Explicit linking language: Secondary hypercoagulable state is linked to the primary diagnosis using language such as 'due to', 'secondary to', 'caused by', or 'associated with'

    Helps support coding to D68.69

    Assessment and plan documented for both the primary condition and the secondary hypercoagulable state

    Include treatment decisions (eg, anticoagulation guided by CHA2DS2-VASc) and follow-up plan

    Inherited primary hypercoagulable disorders (for example, Factor V Leiden and protein C or S deficiencies) are not considered secondary hypercoagulable states and should not be documented as such. When the hypercoagulable state is due to an underlying condition, document the primary cause explicitly and use the diagnosis code D68.69 for secondary hypercoagulable state only when the linkage to a non‑inherited cause is clear.

    Diagnosis Coding and Examples

    Diagnosis codes cited in examplesICD-10Covered
    D68.69Other thrombophilia; Secondary hypercoagulable state
    I48.19Other persistent atrial fibrillation
    C50.911Primary Malignant Neoplasm of Right Female Breast
    C79.51Secondary Malignant Neoplasm of Bone

    Provider Actions and Documentation Requirements

    Prior Authorization

    Diagnosis coding requirement: use D68.69 and specify primary cause

    Document the secondary hypercoagulable state using ICD-10 code D68.69 and specify the primary cause (for example, atrial fibrillation or malignancy) to support medical necessity and accurate coding.

    • Use diagnosis code D68.69 (Other thrombophilia; Secondary hypercoagulable state).
    • Explicitly state the primary condition responsible (e.g., atrial fibrillation, malignancy) in the same assessment entry.
    Note

    Additional provider actions for complete documentation

    Ensure documentation includes clear statements that link the secondary hypercoagulable state to an underlying cause, document the status of the primary condition, and record an assessment and plan for both conditions.

    • If applicable, record treatments related to both the primary condition and anticoagulation decisions (examples: continue Eliquis for atrial fibrillation; follow oncology treatment for malignancy).
    • Include examples shown in the policy (atrial fibrillation, active cancer) when documenting similar cases.
    Documentation Required

    Required documentation elements

    Include the primary condition responsible for the hypercoagulable state, use explicit linking language (for example, 'due to', 'secondary to', 'caused by', or 'associated with'), and document assessment and plan for both the primary and secondary conditions.

    • Document the primary diagnosis and its status (e.g., other persistent atrial fibrillation I48.19; primary and secondary malignancy codes).
    • Record treatment decisions and follow-up for both the primary condition and the secondary hypercoagulable state (e.g., anticoagulation management).
    Denial Risk

    Risk: missing linkage may cause denial or miscoding

    Failure to identify the primary condition causing the hypercoagulable state or to explicitly link the secondary condition back to the primary diagnosis may result in improper diagnosis capture and administrative denials or miscoding.

    • Omitting linking language (eg, 'due to', 'secondary to') risks denial or coding errors.
    • Not documenting assessment and plan for both conditions may undermine medical necessity justification.

    Background

    A secondary hypercoagulable state describes an increased risk of thromboembolism that is caused by an underlying disease or condition. Common examples include hypercoagulability associated with atrial fibrillation and COVID‑19. By definition, this term excludes inherited or primary thrombophilias such as Factor V Leiden or protein C or S deficiencies. Use clinical documentation to name the primary condition and explicitly link it to the secondary hypercoagulable state to support accurate coding and management.

    Key Definitions

    Secondary hypercoagulable state — definition and exclusions
    DefinitionIncreased risk of thromboembolism caused by an underlying disease or condition (eg, atrial fibrillation, COVID-19).
    Exclusion — inherited primary disordersInherited primary hypercoagulable disorders (eg, Factor V Leiden, protein C or S deficiencies) are NOT considered secondary hypercoagulable states and should be documented separately.
    ICD-10 codeD68.69 — Other thrombophilia; Secondary hypercoagulable state
    Common causes (examples)Atrial fibrillation; COVID-19; active malignancy (secondary states are attributable to an underlying primary condition).
    Policy Summary
    Payerwellsense_health_plan
    PolicySecondary Hypercoagulable State Documentation Best Practices
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateN/A
    Next Review DateN/A
    Key ActionDocument the primary condition causing the hypercoagulable state and link it explicitly to the secondary hypercoagulable state (eg, 'due to' or 'secondary to') and include assessment and plan for both.
    SourceLink
    On This Page
    Coverage CriteriaDiagnosis Coding and ExamplesProvider Actions and Documentation RequirementsBackgroundKey Definitions